Literature DB >> 22403130

Catheter-directed foam sclerotherapy treatment of saphenous vein incompetence.

Giuseppe Asciutto1, Bengt Lindblad.   

Abstract

BACKGROUND: The aim of this study is to report the short-term results of catheter-directed foam sclerotherapy (CDFS) in the treatment of axial saphenous vein incompetence. PATIENTS AND METHODS: Data of all patients undergoing CDFS for symptomatic primary incompetence of the great or small saphenous vein were prospectively collected. Treatment results in terms of occlusion rate and patients' grade of satisfaction were analysed. All successfully treated patients underwent clinical and duplex follow-up examinations one year postoperatively.
RESULTS: Between September 2006 and September 2010, 357 limbs (337 patients) were treated with CDFS at our institution. Based on the CEAP classification, 64 were allocated to clinical class C3 , 128 to class C4, 102 to class C5 and 63 to class C6. Of the 188 patients who completed the one year follow up examination, 67 % had a complete and 14 % a near complete obliteration of the treated vessel. An ulcer-healing rate of 54 % was detected. 92 % of the patients were satisfied with the results of treatment. We registered six cases of thrombophlebitis and two cases of venous thromboembolism, all requiring treatment.
CONCLUSIONS: The short-term results of CDFS in patients with axial vein incompetence are acceptable in terms of occlusion and complications rates.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22403130     DOI: 10.1024/0301-1526/a000174

Source DB:  PubMed          Journal:  Vasa        ISSN: 0301-1526            Impact factor:   1.961


  2 in total

1.  Treatment of Recurrent Symptomatic Saphenous Trunk Reflux with Catheter Directed Foam Sclerotherapy and Tumescent Anaesthesia.

Authors:  Luis Leiva Hernando; Agustín Arroyo Bielsa; Juan Carlos Fletes Lacayo
Journal:  EJVES Vasc Forum       Date:  2022-01-22

2.  A new option for endovascular treatment of leg ulcers caused by venous insufficiency with fluoroscopically guided sclerotherapy.

Authors:  Jerzy Garcarek; Aleksander Falkowski; Zbigniew Rybak; Tomasz Jargiello; Marek Łokaj; Norbert Czapla; Magdalena Sroczyk-Jaszczyńska
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2015-09-14       Impact factor: 1.195

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.